IRCCS Sacro Cuore Don Calabria hospital
Negrar, Verona, 37024, Italy
Location status: Recruiting
Location contact
Dora Buonfrate
CONTACT
Dora Buonfrate
SUB_INVESTIGATOR
Zeno Bisoffi
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05770765
This is the protocol that formalizes the establishment of the TROPICA-BIOBANK biobank
Interested in participating?
Request InfoAll sexes
Observational
Negrar, Verona, 37024, Italy
Location status: Recruiting
Dora Buonfrate
CONTACT
Dora Buonfrate
SUB_INVESTIGATOR
Zeno Bisoffi
PRINCIPAL_INVESTIGATOR
Subjects who will access the Department of Infectious and Tropical Diseases for investigations, analyzes or visits on suspicion of infectious or tropical disease, hospitalized patients and/or patients participating in proposed clinical trials from the Department will be enrolled. Healthy volunteer donors may also be enrolled.
The type of samples collected and stored in the biobank consists of human biological matrices liquids and solids, DNA, protein extracts or subcellular fractions, bacterial isolates and arthropods taken from patients. The collection of samples takes place through the support of various professional figures (doctor, nurse, laboratory technician, biologist/biotechnologist) together with associated data.
The samples are de-identified and protected by an encryption system (through the system computer diagnostic data management of the laboratory of the IRCCS Sacro Cuore Don Calabria) and stored at a temperature of -80°C, in the Department's freezers. Samples are stored for 40 years. In order to monitor the quality of the samples over the storage time, a selection of samples used as monthly analytical quality controls will be retested periodically (every 10 years). At the end of the storage time, it will be evaluated whether to extend the storage time of the unused biological samples and associated data or if these will be destroyed. In the first case, an amendment to this Protocol will be submitted to the CESC for approval, in which will specify the duration of the extension of the conservation of the samples and associated data. In the second case, no further data will be collected on the aforementioned samples, without prejudice to their use of those possibly already collected to determine, without altering them, the results of searches already in progress.
The samples will in any case be destroyed if they are not in good condition.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 40 years
Result of laboratory tests on the pathogen responsible for the disease of interest
Contact information is provided by the study sponsor or research team.
IRCCS Sacro Cuore Don Calabria di Negrar
Other
Acronym: TropicaBiobank
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00006150
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Bethesda, Maryland, United States
View Trial DetailsNCT07220915
Agammaglobulinemia, Autoimmune Conditions
Scottsdale, Arizona, United States
View Trial DetailsNCT07607470
Bacterial Infections, Bacterial Infections and Mycoses
North Miami, Florida, United States
View Trial DetailsNCT00967785
Agammaglobulinemia, Agranulocytosis
Bethesda, Maryland, United States
View Trial Details